Jump Financial’s Arcus Biosciences RCUS Stock Holding History

Jump Financial’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.93M	Buy	+135,800	New	+$2.93M	0.04%	516
2025 Q1	–	Sell	-17,244	Closed	-$257K	–	1946
2024 Q4	$257K	Buy	+17,244	New	+$282K	0.01%	1384
2024 Q2	–	Sell	-32,190	Closed	-$608K	–	2176
2024 Q1	$608K	Buy	+32,190	New	+$557K	0.02%	1066
2023 Q3	–	Sell	-63,921	Closed	-$1.3M	–	2175
2023 Q2	$1.3M	Buy	+63,921	New	+$1.22M	0.05%	554
2022 Q1	–	Sell	-9,783	Closed	-$396K	–	1847
2021 Q4	$396K	Buy	+9,783	New	+$379K	0.02%	763
2021 Q1	–	Sell	-17,359	Closed	-$451K	–	1223
2020 Q4	$451K	Sell	17,359 -2,776	-14%	-$67.2K	0.08%	413
2020 Q3	$345K	Buy	+20,135	New	+$450K	0.07%	449

Other funds holding RCUS

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Jump Financial's RCUS Position: Q1 2026 in Review

Jump Financial opened a new position in Arcus Biosciences (RCUS) in Q1 2026: 135,800 shares worth $2.93M. The stake represents 0.04% of the portfolio and ranks #516 among its holdings. This is a return to the name: Jump Financial previously reported a position in RCUS as recently as Q4 2024.

Jump Financial first reported a position in RCUS in Q3 2020 and has held it in 7 quarters since. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

Jump Financial held 135,800 shares of Arcus Biosciences worth $2.93M as of Q1 2026.
Arcus Biosciences was a new Jump Financial position in Q1 2026.
Arcus Biosciences made up 0.04% of Jump Financial's portfolio in Q1 2026, its #516 holding.
Jump Financial first reported a position in Arcus Biosciences in Q3 2020 and has held it in 7 quarters since.
210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.